T. Andrew Crockett
2019
In 2019, T. Andrew Crockett earned a total compensation of $3.3M as Chief Executive Officer at Carbylan Therapeutics, a 61% increase compared to previous year.
Compensation breakdown
Bonus | $353,500 |
---|---|
Option Awards | $2,418,444 |
Salary | $505,000 |
Other | $11,000 |
Total | $3,287,944 |
Crockett received $2.4M in option awards, accounting for 74% of the total pay in 2019.
Crockett also received $353.5K in bonus, $505K in salary and $11K in other compensation.
Rankings
In 2019, T. Andrew Crockett's compensation ranked 3,711th out of 13,971 executives tracked by ExecPay. In other words, Crockett earned more than 73.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,711 | 73rd |
Manufacturing | 1,339 | 77th |
Chemicals And Allied Products | 465 | 79th |
Drugs | 390 | 79th |
Pharmaceutical Preparations | 294 | 79th |
Crockett's colleagues
We found three more compensation records of executives who worked with T. Andrew Crockett at Carbylan Therapeutics in 2019.